arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

LB Pharmaceuticals Inc

LBRX Health Care Biotechnology: Pharmaceutical Preparations
$49.34
Today
as of Sep 4, 16:51 ET
Last 30 days +41.86% Jul 27 → Sep 04
$33.60 $37.87 $42.13 $46.39 $50.66 Jul 27 Aug 04 Aug 12 Aug 19 Aug 27 Sep 04
Open
$47.47
High
$49.87
Low
$47.47
Volume
$205,855
Avg Vol
$277,117
Mkt Cap
$1.4B
P/E (TTM)
—
Beta
—
52w High
$50.16
52w Low
$13.36
Div Yield
—
Shares Out
$29M

Recent Press Releases & News last 60 days · 1 item

Sep 4 · 10:15 Simply Wall St.
2 Reasons LB Pharmaceuticals (LBRX) Looks Pricey Following Its CFO Appointment

Overview

52-week range
$13
$50
98% of range
Avg surprise (last 1)
+10.7%
Avg reaction (last 1)
-4.8%
0% positive
Latest IV / EM
66%
EM ±10.3% · $50 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-39.49$-29.77$-20.05$-10.33$-0.61 Actual $-39.49Actual $-14.79Actual $-13.58Actual $-0.61Actual $-0.67Est $-0.75Actual $-1.71 SepMarJunSepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-52M$-40M$-28M$-16M$-4M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-1.71 — — — — financials
Tue May 12, 2026Mar/2026 $-0.67 $-0.75 +10.7% — -4.8% earnings
Tue Sep 30, 2025Sep 2025 $-0.61 — — — — financials
Mon Jun 30, 2025Jun 2025 $-13.58 — — — — financials
Mon Mar 31, 2025Mar 2025 $-14.79 — — — — financials
Mon Sep 30, 2024Sep 2024 $-39.49 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue————————
Gross profit————————
Operating income————————
Net income$-52M$-19M—$-4M$-5M$-5M—$-14M
EPS (diluted)$-1.71$-0.67—$-0.61$-13.58$-14.79—$-39.49

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$283M$321M$250M$270M——$23M—
Inventory————————
Total current assets$355M$389M$308M$316M——$29M—
Total assets$362M$393M$313M$321M——$34M—
Long-term debt————————
Total liabilities$29M$15M$12M$11M——$14M—
Total equity$332M$379M$301M$310M$-104M$-99M$-95M$-91M

Implied volatility — last 90 days

58%143%228%314%399% Jun 07 — IV 139% · EM ±19.3%Jun 11 — IV 162% · EM ±17.9%Jun 19 — IV 84% · EM ±18.5%Jun 22 — IV 87% · EM ±18.2%Jun 23 — IV 89% · EM ±18.3%Jun 24 — IV 92% · EM ±18.4%Jun 25 — IV 98% · EM ±19.2%Jun 26 — IV 99% · EM ±19.0%Jun 29 — IV 138% · EM ±24.5%Jun 30 — IV 127% · EM ±21.9%Jul 01 — IV 135% · EM ±22.6%Jul 02 — IV 120% · EM ±19.4%Jul 03 — IV 124% · EM ±19.4%Jul 06 — IV 119% · EM ±16.5%Jul 07 — IV 113% · EM ±14.9%Jul 08 — IV 133% · EM ±16.7%Jul 09 — IV 128% · EM ±15.1%Jul 10 — IV 140% · EM ±15.5%Jul 13 — IV 238% · EM ±19.8%Jul 14 — IV 255% · EM ±18.4%Jul 16 — IV 399% · EM ±16.7%Jul 20 — IV 114% · EM ±26.9%Jul 21 — IV 74% · EM ±17.2%Jul 22 — IV 92% · EM ±21.0%Jul 23 — IV 80% · EM ±18.1%Jul 24 — IV 84% · EM ±18.6%Jul 27 — IV 91% · EM ±19.0%Jul 28 — IV 84% · EM ±17.2%Jul 29 — IV 90% · EM ±17.9%Jul 30 — IV 62% · EM ±12.1%Jul 31 — IV 68% · EM ±13.0%Aug 03 — IV 79% · EM ±14.0%Aug 04 — IV 78% · EM ±13.4%Aug 05 — IV 68% · EM ±11.4%Aug 06 — IV 72% · EM ±11.6%Aug 07 — IV 81% · EM ±12.7%Aug 10 — IV 80% · EM ±11.0%Aug 11 — IV 85% · EM ±11.3%Aug 12 — IV 75% · EM ±9.4%Aug 13 — IV 90% · EM ±10.7%Aug 14 — IV 138% · EM ±15.3%Aug 17 — IV 102% · EM ±8.5%Aug 18 — IV 179% · EM ±12.9%Aug 19 — IV 176% · EM ±10.4%Aug 20 — IV 273% · EM ±11.4%Aug 24 — IV 65% · EM ±13.6%Aug 25 — IV 59% · EM ±12.0%Aug 26 — IV 74% · EM ±14.8%Aug 27 — IV 64% · EM ±12.6%Aug 28 — IV 73% · EM ±13.9%Aug 31 — IV 62% · EM ±10.9%Sep 01 — IV 64% · EM ±10.9%Sep 02 — IV 62% · EM ±10.3%Sep 03 — IV 78% · EM ±12.6%Sep 04 — IV 66% · EM ±10.3%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in